Report of the PMDA-ATC Clinical Trial Webinar 2026 for FDA Philippines, Philippines

On February 5, the PMDA held the " PMDA-ATC Clinical Trial Webinar 2026 for FDA Philippines, Philippines." This topic was selected based on the request from FDA Philippines.
There were 34 regulators attended from FDA Philippines who are engaged in clinical trial assessment and GCP inspection. 
PMDA staff members provided lectures on Japanese clinical trial notification system, review of safety report from clinical trial as well as new ICH guideline published as E6 (R3). In the Q&A session, participants engaged interactively with the lecturers through active questions and practical discussions.
The PMDA continues to provide training opportunities and contributes to capacity building of FDA Philippines.

See attached program [150KB]